SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-037749
Filing Date
2010-04-23
Accepted
2010-04-23 17:25:36
Documents
2
Period of Report
2010-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c99596e8vk.htm 8-K 13874
2 EXHIBIT 10.115 c99596exv10w115.htm EX-10.115 129115
  Complete submission text file 0000950123-10-037749.txt   144638
Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26483 | Film No.: 10768167
SIC: 2834 Pharmaceutical Preparations